Document is current
Any future updates will be listed below
-
Authors
Koshizaka, Masaya https://orcid.org/0000-0001-7374-9993
Tatsumi, Tomoaki https://orcid.org/0000-0001-8271-9403
Kiyonaga, Fumiko
Kosakai, Yoshinori
Yoshinaga, Yoko
Shintani-Tachi, Mami
-
Funding
Funding for this research was provided by:
Astellas Pharma
- License Information
-
More Information
Article History
Received: 11 July 2024
Accepted: 30 August 2024
First Online: 30 September 2024
Declarations
:
: Masaya Koshizaka and Tomoaki Tatsumi do not have any conflicts of interest to declare. Fumiko Kiyonaga, Yoshinori Kosakai, and Mami Shintani-Tachi are employees of Astellas Pharma Inc. Yoko Yoshinaga is a former employee of Astellas Pharma Inc. and a current employee of Eli Lilly Japan K.K.
: The study protocol was approved by the Medical Affairs Japan – Protocol Review Committee of Astellas Pharma Inc. (protocol number: 1941-MA-3477). The study was conducted in accordance with the protocol, the ethical principles of the Declaration of Helsinki, and all applicable regulations and guidelines governing clinical study conduct. Patient informed consent was not required because data used in this study were retrospectively collected and were deidentified.
